https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Vascular-MC.jpg

Implantable Ports Market Analysis | China | 2017-2023 | MedCore

  • Year: 2017
  • Scope: 2013-2023
  • Region: China
  • Pages: 366
  • Published Date: 2/1/2017
  • Type: MedCore

The implantable ports market will experience high single-digit growth owing to product innovations such as power-injectable implantable ports, dual lumen ports and arm ports. Multi-lumen implantable ports are selling better than previously anticipated. Furthermore, the use of implantable ports in China is on the rise as a spike in the incidence of cancer severely affected the country. According to the World Health Organization, over three million newly diagnosed cases of cancer were recorded in China in 2012. The increasing use of chemotherapy will require implantable ports.

The Chinese market for implantable ports comprises conventional implantable ports and power -injectable implantable ports. Conventional implantable ports are defined as implantable ports that do not feature power-injection.

Segments Covered in This Market

  • Conventional Implantable Ports Market
  • Power-Injectable Implantable Ports Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

C. R. Bard was the leading competitor in the implantable port market in China in 2016. They are one of the worldwide leaders in the port market and have benefited from the growth of venous ports to gain market share in countries such as South Korea and Japan. Founded in 1995, Beijing Zhaoshi Medical has set up a nationwide sales network in China, and also sells heavily to foreign countries. B. Braun is the manufacturer of the Celsite® implantable port, while Toray Medical makes the adjoining catheter and distributes the combined product in Korea.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled China Market Report Suite for Vascular Access Devices and Accessories – MedSuite

Learn More about these product types

TABLE OF CONTENTS ILIST OF FIGURES XVILIST OF CHARTS XIXEXECUTIVE SUMMARY 1CHINA VASCULAR ACCESS DEVICE AND ACCESSORIES MARKET OVERVIEW 1COMPETITIVE ANALYSIS 3MARKET TRENDS 5MARKET DEVELOPMENTS 6MARKETS INCLUDED 7KEY REPORT UPDATES 8VERSION HISTORY 8RESEARCH METHODOLOGY 91.1 RESEARCH SCOPE 91.2 IDATA’S 9-STEP METHODOLOGY 91.2.1 Step 1: Project Initiation & Team Selection 91.2.2 Step 2: Prepare Data Systems and Perform Secondary Research 111.2.3 Step 3: Preparation for Interviews & Questionnaire Design 121.2.4 Step 4: Performing Primary Research 131.2.5 Step 5: Research Analysis: Establishing Baseline Estimates 151.2.6 Step 6: Market Forecast and Analysis 161.2.7 Step 7: Identify Strategic Opportunities 181.2.8 Step 8: Final Review and Market Release 191.2.9 Step 9: Customer Feedback and Market Monitoring 20DISEASE OVERVIEW 212.1 BASIC ANATOMY 212.1.1 Human Vascular System 212.2 VASCULAR PATHOLOGY AND DISORDERS 222.2.1 Cancer 222.2.2 End-Stage Renal Disease 232.2.3 Diabetes 25PRODUCT ASSESSMENT 283.1 PRODUCT PORTFOLIOS 283.1.1 Implantable Port Devices 283.1.1.1 Introduction 283.1.1.1.1 Implantable Port Patients 283.1.1.1.2 Port Implantation Procedures 293.1.1.1.3 Port Infusion 293.1.1.1.4 Port Maintenance 303.1.1.2 AngioDynamics 303.1.1.2.1 BioFlo® 303.1.1.2.2 LifePort® 303.1.1.2.3 Smart Port® CT 303.1.1.2.4 TitanPort® 303.1.1.2.5 Triumph-1® 313.1.1.2.6 Vortex® 313.1.1.2.7 Xcela™ Plus 313.1.1.3 B. Braun 313.1.1.3.1 Celsite® 313.1.1.4 Cook Medical 313.1.1.4.1 Vital-Port® 313.1.1.5 C.R. Bard 323.1.1.5.1 PowerPort® 323.1.1.5.2 SlimPort® 323.1.1.5.3 X-Port™ 323.1.1.5.4 Other Port Offerings 323.1.1.6 Medcomp 323.1.1.6.1 Dignity® 323.1.1.6.2 Pro-Fuse® CT 333.1.1.7 PFM Medical 333.1.1.7.1 T-Port™ 333.1.1.7.2 TitaJet™ 333.1.1.7.3 Jet Port® 333.1.1.7.4 DualPort 333.1.1.8 Smiths Medical 333.1.1.8.1 P.A.S. PORT® 333.1.1.8.2 PORT-A-CATH® 343.1.1.9 Teleflex Medical 343.1.1.9.1 Polysite® 343.2 REGULATORY ISSUES AND RECALLS 353.2.1 November 2015 353.2.2 October 2015 353.2.3 September 2015 363.2.4 August 2015 383.2.5 July 2015 393.2.6 April 2015 413.2.7 March 2015 423.2.8 February 2015 433.2.9 January 2015 433.2.10 December 2014 443.2.11 October 2014 453.2.12 September 2014 463.2.13 May 2014 473.2.14 April 2014 473.2.15 March 2014 483.2.16 January 2014 483.2.17 December 2013 493.2.18 September 2013 503.2.19 August 2013 513.2.20 June 2013 513.2.21 March 2013 523.2.22 February 2013 533.2.23 December 2012 533.2.24 August 2012 533.2.25 June 2012 543.2.26 May 2012 553.2.27 March 2012 563.2.28 February 2012 573.2.29 January 2012 573.3 CLINICAL TRIALS 613.3.1 Implantable Port Devices 623.4 PRODUCT PIPELINES 643.4.1 Alliance Vascular Devices, LLC 643.4.1.1 FreeHand Safety Huber Needle® 643.4.2 AngioDynamics 643.4.2.1 Celerity™ PICC Tip Confirmation System with Navigation 643.4.2.2 Firefly 643.4.2.3 BioFlo® PICC Line Extension 653.4.2.4 BioFlo® Port Line Extension 653.4.2.5 Next Generation BioFlo® PICC 653.4.2.6 Next Generation BioFlo® Port 653.4.3 Bluegrass Vascular Technologies, Inc. 653.4.3.1 Surfacer® Inside-Out™ Access System 653.4.4 C.R. Bard 653.4.4.1 Chemical-Resistant PICCs 653.4.4.2 Novel Advanced Material PICCs 663.4.4.3 PowerGlide® Pro Midline 663.4.4.4 AccuCath® 663.4.4.5 Xenesis™ Acute Hemodialysis Catheter 663.4.4.6 Site~Rite® 8 Ultrasound System 663.4.5 M. C. Johnson 663.4.5.1 PICC Securement Device 663.4.6 Nipro Medical 673.4.6.1 Shielding Safety Needle 673.4.6.2 Safety Syringe 673.4.6.3 Safety PIVC 673.4.7 Parasol Medical 673.4.7.1 Catheter Securement Device 673.4.8 PAVmed Inc. 673.4.8.1 NextCath™ 673.4.9 Phase One Medical 673.4.9.1 Goldilocks™ Long Term Hemodialysis Catheter 673.4.9.2 Triple-Lumen Symetrex™ Hemodialysis Catheter 683.4.10 Prodigy Diabetes Care, LLC. 683.4.10.1 Insulin Pen Needles 683.4.11 Sharklet Technologies, Inc. 683.4.11.1 Sharklet™ Central Venous Catheter 683.4.12 Starboard Medical 683.4.12.1 Catheter Securement Devices 683.4.13 Teleflex Medical 693.4.13.1 Arrow® Endurance™ Extended Dwell Peripheral Catheter System 693.4.13.2 Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports 693.4.14 Vascular Access Technologies, Inc. 693.4.14.1 SAFECVAD™ 69IMPLANTABLE PORT MARKET 704.1 MARKET OVERVIEW 704.2 MARKET ANALYSIS AND FORECAST 744.2.1 Total Implantable Port Market 744.2.2 Conventional Implantable Port Market 764.2.3 Power-Injectable Implantable Port Market 784.3 DRIVERS AND LIMITERS 804.3.1 Market Drivers 804.3.2 Market Limiters 804.4 COMPETITIVE MARKET SHARE ANALYSIS 82ABBREVIATIONS 85APPENDIX: COMPANY PRESS RELEASES 86
The "China Market Report Suite for Vascular Access Devices and Accessories 2017 - MedSuite" includes analysis on the following companies currently active in this market:CR BardTeleflexBDB BraunSmiths MedicalMedtronicCook MedicalOthers include: Changzhou Yuandong Medical, Henan Concerone Industry Co., Heze Sinorgmed Polymers Co., Jiangsu Province Huaxing Medical, Jiangxi Sanxin Medtec Co., Lepu Medical Technology, Longreal Medevice Limited, Melson Medical Corporation Limited, Nanjing Hoshin Medical Instrument Co., Ningbo Win-Win Medical Instruments, Poweam Medical, Qingdao Joyjun Medical Products Co, Qingdao Medical Import & Export Co., Shandong Sinorgmed Co., Ltd., Shanghai Hengxin Medical Devices, Shanghai Madicare Co., Zibo Eastmed Healthcare Products, etc *Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.
Chart 1 1: Vascular Access Device and Accessories Market by Segment China, 2013 – 2023 2Chart 1 2: Vascular Access Device and Accessories Market China, 2016 & 2023 2Chart 4 1: Implantable Port Market by Segment, China, 2013 – 2023 72Chart 4 2: Implantable Port Market Breakdown, China, 2016 73Chart 4 3: Implantable Port Market Breakdown, China, 2023 73Chart 4 4: Total Implantable Port Market, China, 2013 – 2023 75Chart 4 5: Conventional Implantable Port Market, China, 2013 – 2023 77Chart 4 6: Power-Injectable Implantable Port Market, China, 2013 – 2023 79Chart 4 7: Leading Competitors, Implantable Port Market, China, 2016 84
Figure 1 1: Leading Competitors by Segment, Vascular Access Device and Accessories Market, China, 2016 (1 of 2) 3Figure 1 2: Leading Competitors by Segment, Vascular Access Device and Accessories Market, China, 2016 (2 of 2) 4Figure 1 3: Companies Researched in this Report, China, 2016 4Figure 1 4: Factors Impacting the Vascular Access Device and Accessories Market, China 5Figure 1 5: Recent Events in the Vascular Access Device and Accessories Market, China, 2012 – 2016 6Figure 1 6: Vascular Access Device and Accessories Markets Covered, China, 2016 7Figure 1 7: Key Report Updates 8Figure 1 8: Version History 8Figure 3 1: Class 2 Device Recall Medtronic 35Figure 3 2: Class 2 Device Recall Smiths Medical 35Figure 3 3: Class 2 Device Recall Arrow 36Figure 3 4: Class 2 Device Recall Arrow 36Figure 3 5: Class 2 Device Recall Covidien (Medtronic) 37Figure 3 6: Class 2 Device Recall Arrow 38Figure 3 7: Class 2 Device Recall Medline 38Figure 3 8: Class 2 Device Recall Arrow 38Figure 3 9: Class 2 Device Recall B. Braun 38Figure 3 10: Class 3 Device Recall Bard Access 39Figure 3 11: Class 2 Device Recall Covidien (Medtronic) 39Figure 3 12: Class 2 Device Recall Bard Access 41Figure 3 13: Class 2 Device Recall Bard Access 41Figure 3 14: Class 2 Device Recall Medcomp & AngioDynamics 42Figure 3 15: Class 2 Device Recall Bard Access 42Figure 3 16: Class 2 Device Recall Arrow 43Figure 3 17: Class 2 Device Recall Medcomp 43Figure 3 18: Class 2 Device Recall Arrow 43Figure 3 19: Class 2 Device Recall Arrow 44Figure 3 20: Class 2 Device Recall Smiths Medical 44Figure 3 21: Class 2 Device Recall PFM Medical 44Figure 3 22: Class 2 Device Recall PFM Medical 44Figure 3 23: Class 2 Device Recall Becton Dickinson 45Figure 3 24: Class 2 Device Recall Arrow 45Figure 3 25: Class 2 Device Recall Arrow 45Figure 3 26: Class 2 Device Recall Navilyst Medical 45Figure 3 27: Class 2 Device Recall Argon Medical 46Figure 3 28: Class 2 Device Recall Arrow 47Figure 3 29: Class 2 Device Recall Arrow 47Figure 3 30: Class 2 Device Recall Arrow 48Figure 3 31: Class 2 Device Recall Bard Access 48Figure 3 32: Class 2 Device Recall Navilyst Medical 48Figure 3 33: Class 2 Device Recall Bard Access 49Figure 3 34: Class 2 Device Recall Smiths Medical 49Figure 3 35: Class 2 Device Recall B. Braun 49Figure 3 36: Class 2 Device Recall Smiths Medical 50Figure 3 37: Class 2 Device Recall Access Scientific 50Figure 3 38: Class 2 Device Recall Covidien (Medtronic) 50Figure 3 39: Class 2 Device Recall Arrow 51Figure 3 40: Class 2 Device Recall Bard Access 51Figure 3 41: Class 2 Device Recall Becton Dickinson 51Figure 3 42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 52Figure 3 43: Class 2 Device Recall Bard Access 52Figure 3 44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 52Figure 3 45: Class 2 Device Recall Medcomp 53Figure 3 46: Class 2 Device Recall Becton Dickinson 53Figure 3 47: Class 3 Device Recall Bard Access 53Figure 3 48: Class 2 Device Recall Medcomp 54Figure 3 49: Class 1 Device Recall Arrow 54Figure 3 50: Class 2 Device Recall Arrow 54Figure 3 51: Class 2 Device Recall Vygon 54Figure 3 52: Class 2 Device Recall Covidien (Medtronic) 55Figure 3 53: Class 2 Device Recall Medcomp 56Figure 3 54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 56Figure 3 55: Class 2 Device Recall Christie Medical Holdings 56Figure 3 56: Class 3 Recall Bard Access 56Figure 3 57: Class 2 Device Recall AngioDynamics 57Figure 3 58: Class 2 Device Recall Becton Dickinson 57Figure 3 59: Class 2 Device Recall AngioDynamics 57Figure 3 60: Class 2 Device Recall AngioDynamics 59Figure 3 61: Class 3 Device Recall AngioDynamics 60Figure 3 62: Class 2 Device Recall AngioDynamics 60Figure 3 63: Bone Anchored Port - a Novel Vascular Access for Hemodialysis Treatment 62Figure 3 64: A Pragmatic Randomized Trial 62Figure 3 65: Assessment of a Power Injectable vs. a Non-Power Injectable 63Figure 3 66: Vascular Access in Cancer Patients 63Figure 3 67: Ultrasound-guided Subclavian Vein Puncture Versus Cephalic Vein Dissection 63Figure 4 1: Implantable Port Market by Segment, China, 2013 – 2023 (US$M) 71Figure 4 2: Implantable Port Market by Segment, China, 2013 – 2023 (CN¥M) 71Figure 4 3: Total Implantable Port Market, China, 2013 – 2023 74Figure 4 4: Conventional Implantable Port Market, China, 2013 – 2023 76Figure 4 5: Power-Injectable Implantable Port Market, China, 2013 – 2023 78Figure 4 6: Drivers and Limiters, Implantable Port Market, China, 2016 81Figure 4 7: Leading Competitors, Implantable Port Market, China, 2016 83Figure 6 1: Press Release Summary 86

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology